Purchases and Sales Made in Q4 2023 in Madrigal Pharmaceuticals, Inc. (MDGL)
This table provides information about the institutional ownership of Madrigal Pharmaceuticals, Inc. (MDGL) during Q4 2023. The information is specifically focused on institutions that hold shares of MADRIGAL PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 14, 2024
Q4 2023
|
Ghost Tree Capital, LLC
New York, NY |
SELL
|
- |
-42.5K- 73.91% |
$5.12M - $10.1M
|
15K
$5.06M
|
|
|
Feb 13, 2024
Q4 2023
|
Armistice Capital, LLC
New York, NY |
SELL
|
- |
-58K- 53.7% |
$6.98M - $13.8M
|
50K
$16.9M
|
|
|
Feb 14, 2024
Q4 2023
|
Schonfeld Strategic Advisors LLC
New York, NY |
SELL
|
- |
-59.1K- 82.58% |
$7.11M - $14M
|
12.5K
$4.2M
|
|
|
Aug 16, 2024
Q4 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-68.1K- 30.96% |
$8.2M - $16.2M
|
152K
$51.2M
|
|
|
Feb 14, 2024
Q4 2023
|
Janus Henderson Group PLC
London, X0 |
SELL
|
- |
-141K- 4.62% |
$16.9M - $33.3M
|
2.9M
$979M
|
|
|
Feb 14, 2024
Q4 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-266K- 96.21% |
$32.1M - $63.2M
|
10.5K
$3.54M
|
|
|
Feb 14, 2024
Q4 2023
|
Marshall Wace, LLP
London, X0 |
SELL
|
- |
-362K- 91.64% |
$43.6M - $85.9M
|
33.1K
$11.2M
|